{"id":118,"date":"2022-09-13T11:50:51","date_gmt":"2022-09-13T11:50:51","guid":{"rendered":"https:\/\/admedsol1stg.wpenginepowered.com\/?page_id=118"},"modified":"2026-03-24T11:20:00","modified_gmt":"2026-03-24T11:20:00","slug":"board-of-directors","status":"publish","type":"page","link":"https:\/\/admedsol.com\/investor-relations\/corporate-governance\/board-of-directors\/","title":{"rendered":"Board of Directors"},"content":{"rendered":"

[et_pb_section fb_built=”1″ module_class=”ams-angle-header white” _builder_version=”4.27.6″ _module_preset=”default” background_image=”https:\/\/admedsol.com\/wp-content\/uploads\/2023\/06\/Board-of-Directors-1.jpg” background_size=”custom” background_image_width=”50%” background_position=”center_right” custom_padding_tablet=”6rem||4rem||false|false” custom_padding_phone=”5rem||4rem||false|false” hover_enabled=”0″ background_last_edited=”on|phone” use_background_color_gradient_tablet=”off” use_background_color_gradient_phone=”on” background_color_gradient_direction_phone=”135deg” background_color_gradient_stops_phone=”#461a46 0%|rgba(119,43,120,0.75) 100%” background_color_gradient_overlays_image_tablet=”on” background_size_tablet=”cover” locked=”off” global_colors_info=”{}” custom_css_before_last_edited=”off|phone” sticky_enabled=”0″][et_pb_row _builder_version=”4.22.2″ _module_preset=”default” custom_margin=”0rem||3.5rem||false|false” custom_margin_tablet=”||0rem||false|false” custom_margin_phone=”||0rem||false|false” custom_margin_last_edited=”on|tablet” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.22.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_code _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

Corporate Governance<\/div>\n

<\/p>\n

Board of Directors<\/h1>\n

<\/p>\n

Contact Us <\/i><\/a><\/div>\n

[\/et_pb_code][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ disabled_on=”on|off|off” module_id=”ams-breadcrumb-section” _builder_version=”4.22.2″ _module_preset=”default” background_color=”rgba(255,255,255,0.9)” custom_margin=”-56px||0px||false|false” custom_padding=”16px||16px||false|false” locked=”off” global_colors_info=”{}”][et_pb_row _builder_version=”4.18.1″ _module_preset=”default” custom_margin=”0px||0px||false|false” custom_padding=”0px||0px||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.18.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_sidebar area=”et_pb_widget_area_1″ module_id=”breadcrumbs” _builder_version=”4.18.1″ _module_preset=”default” custom_margin=”0px||0px||false|false” custom_padding=”0px||0px||false|false” global_colors_info=”{}”][\/et_pb_sidebar][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.22.1″ _module_preset=”default” custom_padding=”6rem||2rem||false|false” custom_padding_tablet=”2rem||1rem||false|false” custom_padding_phone=”2rem||1rem||false|false” global_colors_info=”{}”][et_pb_row _builder_version=”4.22.1″ _module_preset=”default” custom_margin=”0rem||2rem||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.21.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_code _builder_version=”4.22.1″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

Committee Membership Key<\/h5>\n

[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_4,1_4,1_4,1_4″ _builder_version=”4.21.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.21.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_code _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

<\/p>\n
A\t<\/div>\n

Audit & Risk Committee<\/div>\n

[\/et_pb_code][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.21.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_code _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

<\/p>\n
R <\/div>\n

Remuneration Committee<\/div>\n

[\/et_pb_code][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.21.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_code _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

<\/p>\n
N <\/div>\n

Nomination Committee<\/div>\n

[\/et_pb_code][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.21.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_code _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

<\/p>\n
<\/div>\n

Committee Chair<\/div>\n

[\/et_pb_code][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.22.1″ _module_preset=”default” custom_padding=”2rem||6rem||false|false” custom_padding_tablet=”1rem||2rem||false|false” custom_padding_phone=”1rem||2rem||false|false” global_colors_info=”{}”][et_pb_row column_structure=”1_3,1_3,1_3″ _builder_version=”4.22.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_3″ _builder_version=”4.21.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/admedsol.com\/wp-content\/uploads\/2023\/08\/grahame-cook.png” title_text=”liz-shanahan” align=”center” module_class=”ams-br-8 ams-bg-purple-4″ _builder_version=”4.27.4″ _module_preset=”default” background_enable_color=”off” height_tablet=”” height_phone=”” height_last_edited=”on|tablet” max_height=”250px” custom_margin=”1rem||1rem||false|false” custom_padding=”0px||0px||false|false” border_radii=”on|0.5rem|0.5rem|0.5rem|0.5rem” global_colors_info=”{}”][\/et_pb_image][et_pb_code _builder_version=”4.27.4″ _module_preset=”default” custom_margin=”1rem||1rem||false|false” custom_padding=”0px||0px||false|false” locked=”off” global_colors_info=”{}”]<\/p>\n

<\/p>\n

Grahame Cook<\/h4>\n

<\/p>\n

Chair of the Board<\/h5>\n

<\/p>\n

<\/p>\n
R<\/div>\n

<\/p>\n

N<\/div>\n

<\/div>\n

<\/div>\n

[\/et_pb_code][et_pb_code _builder_version=”4.22.1″ _module_preset=”default” custom_margin=”1rem||1.5rem||false|false” custom_padding=”0px||0px||false|false” global_colors_info=”{}”]<\/p>\n

<\/div>\n

[\/et_pb_code][et_pb_accordion open_toggle_text_color=”#03305D” open_toggle_background_color=”#ffffff” closed_toggle_background_color=”#ffffff” icon_color=”#0B629F” module_class=”ams-divi-accordion” _builder_version=”4.27.4″ _module_preset=”default” toggle_text_color=”#0B629F” toggle_font=”|700|||||||” body_font=”|300|||||||” custom_margin=”0px||0px||false|false” custom_padding=”0.5rem|0px|0px|0px|false|true” border_width_all=”0px” border_color_all=”#f8f8f8″ locked=”off” global_colors_info=”{}”][et_pb_accordion_item title=”Biography” open=”on” _builder_version=”4.22.1″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

Grahame Cook has 18 years of experience in investment banking focusing on global equity capital markets and M&A and corporate advisory services. He was a Managing Director at UBS and joint Chief Executive of Panmure Gordon. He advised the London Stock Exchange on the creation of TechMark, the specialist segment of the Main Market focusing on innovative technology and healthcare companies. He has experience in the healthcare sector, most recently as Chair of Sinclair Pharma plc and as NonExecutive Director of Morphogenesis Inc. and Horizon Discovery plc. He has also held Board positions in a number of other companies including MDY Healthcare plc and Crawford Healthcare.<\/p>\n

He holds a double first-class degree from Oxford University and is a member of the Institute of Chartered Accountants.<\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=”Term of office” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}” open=”off”]<\/p>\n

Grahame Cook was appointed as Non-Executive Director of AMS in February 2021 and as Chair in March 2025<\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=”External appointments” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}” open=”off”]<\/p>\n

Grahame Cook is Chair of Molten plc, a FTSE 250 Company, and a Non-Executive Director of Minoan plc and Sapience Communications Limited.<\/p>\n

[\/et_pb_accordion_item][\/et_pb_accordion][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.21.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/admedsol.com\/wp-content\/uploads\/2023\/08\/chris-meredith.png” title_text=”chris-meredith” align=”center” module_class=”ams-br-8 ams-bg-green-4″ _builder_version=”4.27.4″ _module_preset=”default” background_enable_color=”off” height_tablet=”” height_phone=”” height_last_edited=”on|tablet” max_height_tablet=”250px” max_height_phone=”250px” max_height_last_edited=”on|tablet” custom_margin=”1rem||1rem||false|false” custom_padding=”0px||0px||false|false” border_radii=”on|0.5rem|0.5rem|0.5rem|0.5rem” global_colors_info=”{}”][\/et_pb_image][et_pb_code _builder_version=”4.27.4″ _module_preset=”default” custom_margin=”1rem||1rem||false|false” custom_padding=”0px||0px||false|false” global_colors_info=”{}”]<\/p>\n

<\/p>\n

Chris Meredith<\/h4>\n

<\/p>\n

Chief Executive Officer<\/h5>\n

<\/div>\n

[\/et_pb_code][et_pb_code _builder_version=”4.22.1″ _module_preset=”default” custom_margin=”1rem||1.5rem||false|false” custom_padding=”0px||0px||false|false” global_colors_info=”{}”]<\/p>\n

<\/div>\n

[\/et_pb_code][et_pb_accordion open_toggle_text_color=”#03305D” open_toggle_background_color=”#ffffff” closed_toggle_background_color=”#ffffff” icon_color=”#0B629F” module_class=”ams-divi-accordion” _builder_version=”4.22.1″ _module_preset=”default” toggle_text_color=”#0B629F” toggle_font=”|700|||||||” body_font=”|300|||||||” custom_margin=”0px||0px||false|false” custom_padding=”0.5rem|0px|0px|0px|false|true” border_width_all=”0px” border_color_all=”#f8f8f8″ global_colors_info=”{}”][et_pb_accordion_item title=”Biography” open=”on” _builder_version=”4.22.1″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

Chris Meredith joined AMS as Group Commercial Director in July 2005 following a successful 18-year career in international healthcare sales, marketing and business development. His experience covered business-to-business contract manufacturing, product development and clinical research, as well as branded product sales all within the medical device, pharmaceutical or consumer healthcare markets. Chris has previously held senior positions at Smiths Industries, Cardinal Health, Banner Pharmacaps, and Aster Cephac. He was appointed Managing Director of Advanced Woundcare in February 2008, became Chief Operating Officer in January 2010 and was appointed as Chief Executive Officer in January 2011.<\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=”Term of office” _builder_version=”4.22.1″ _module_preset=”default” global_colors_info=”{}” open=”off”]<\/p>\n

Chris Meredith was appointed to the Board in April 2006.<\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=”External appointments” _builder_version=”4.22.1″ _module_preset=”default” global_colors_info=”{}” open=”off”]<\/p>\n

Chris Meredith was appointed Chair of Arterius, a UK-based pre-commercial, non-competitive medical device company, in January 2022. He left his role as a Non-Executive Director of Creavo Medical Technology Ltd in November 2021.<\/p>\n

[\/et_pb_accordion_item][\/et_pb_accordion][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.21.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/admedsol.com\/wp-content\/uploads\/2023\/08\/eddie-johnson.png” title_text=”eddie-johnson” align=”center” module_class=”ams-br-8 ams-bg-teal-3″ _builder_version=”4.27.4″ _module_preset=”default” background_enable_color=”off” max_height_tablet=”250px” max_height_phone=”250px” max_height_last_edited=”on|tablet” custom_margin=”1rem||1rem||false|false” custom_padding=”0px||0px||false|false” border_radii=”on|0.5rem|0.5rem|0.5rem|0.5rem” global_colors_info=”{}”][\/et_pb_image][et_pb_code _builder_version=”4.25.2″ _module_preset=”default” custom_margin=”1rem||1rem||false|false” custom_padding=”0px||0px||false|false” global_colors_info=”{}”]<\/p>\n

<\/p>\n

Eddie Johnson<\/h4>\n

<\/p>\n

Chief Financial Officer<\/h5>\n

<\/div>\n

[\/et_pb_code][et_pb_code _builder_version=”4.22.1″ _module_preset=”default” custom_margin=”1rem||1.5rem||false|false” custom_padding=”0px||0px||false|false” global_colors_info=”{}”]<\/p>\n

<\/div>\n

[\/et_pb_code][et_pb_accordion open_toggle_text_color=”#03305D” open_toggle_background_color=”#ffffff” closed_toggle_background_color=”#ffffff” icon_color=”#0B629F” module_class=”ams-divi-accordion” _builder_version=”4.22.1″ _module_preset=”default” toggle_text_color=”#0B629F” toggle_font=”|700|||||||” body_font=”|300|||||||” custom_margin=”0px||0px||false|false” custom_padding=”0.5rem|0px|0px|0px|false|true” border_width_all=”0px” border_color_all=”#f8f8f8″ global_colors_info=”{}”][et_pb_accordion_item title=”Biography” open=”on” _builder_version=”4.22.1″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

Eddie Johnson was appointed as Chief Financial Officer in January 2019. He joined AMS in October 2011 and was appointed Group Financial Controller in November 2012. Prior to this he gained a first-class degree in Maths and Computer Science from Keele University in 1993 and qualified as a Chartered Accountant in 1996.<\/p>\n

Since moving into industry in 1996 Eddie has held a number of senior finance roles in various sectors including, more recently, Head of Commercial Finance at Norcros plc and Western European Financial Controller for Sumitomo Electrical Wiring Systems.<\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=”Term of office” _builder_version=”4.22.1″ _module_preset=”default” global_colors_info=”{}” open=”off”]<\/p>\n

Eddie Johnson was appointed to the Board in January 2019.<\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=”External appointments” _builder_version=”4.22.1″ _module_preset=”default” global_colors_info=”{}” open=”off”]<\/p>\n

None.<\/p>\n

[\/et_pb_accordion_item][\/et_pb_accordion][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_3,1_3,1_3″ _builder_version=”4.21.0″ _module_preset=”default” custom_margin=”2rem||0rem||false|false” global_colors_info=”{}”][et_pb_column type=”1_3″ _builder_version=”4.21.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/admedsol.com\/wp-content\/uploads\/2026\/02\/Susan-No-Background.png” title_text=”Susan-No-Background” align=”center” module_class=”ams-br-8 ams-bg-purple-5″ _builder_version=”4.27.5″ _module_preset=”default” background_enable_color=”off” height_tablet=”” height_phone=”” height_last_edited=”on|tablet” max_height=”250px” custom_margin=”1rem||1rem||false|false” custom_padding=”0px||0px||false|false” border_radii=”on|0.5rem|0.5rem|0.5rem|0.5rem” global_colors_info=”{}”][\/et_pb_image][et_pb_code _builder_version=”4.27.4″ _module_preset=”default” custom_margin=”1rem||1rem||false|false” custom_padding=”0px||0px||false|false” global_colors_info=”{}”]<\/p>\n

<\/p>\n

Susan Searle<\/h4>\n

<\/p>\n

Senior Independent Non-Executive Director<\/h5>\n

<\/p>\n

<\/p>\n
A<\/div>\n

<\/p>\n

R<\/div>\n

<\/p>\n

N<\/div>\n

<\/div>\n

<\/div>\n

[\/et_pb_code][et_pb_code _builder_version=”4.21.0″ _module_preset=”default” custom_margin=”1rem||1rem||false|false” custom_padding=”0px||0px||false|false” global_colors_info=”{}”]<\/p>\n

<\/div>\n

[\/et_pb_code][et_pb_accordion open_toggle_text_color=”#03305D” open_toggle_background_color=”#ffffff” closed_toggle_background_color=”#ffffff” icon_color=”#0B629F” module_class=”ams-divi-accordion” _builder_version=”4.27.4″ _module_preset=”default” toggle_text_color=”#0B629F” toggle_font=”|700|||||||” body_font=”|300|||||||” custom_margin=”0px||0px||false|false” custom_padding=”0.5rem|0px|0px|0px|false|true” border_width_all=”0px” border_color_all=”#f8f8f8″ global_colors_info=”{}”][et_pb_accordion_item title=”Biography” open=”on” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

Susan has extensive experience on public and private company boards in a number of sectors, including healthcare. Susan was formerly Non-Executive Senior Independent Director and Remuneration Chair of Horizon Discovery plc and Benchmark Holdings Plc, both technology businesses. She also chaired two listed investment businesses \u2013 Mercia Asset Management plc and Schroders UK Public Private Trust plc, and was a founder of Touchstone Innovations plc, where she served as its CEO. She has recently stepped down from QinetiQ plc where she was a Non-Executive Director and Remuneration Committee Chair, having served three full terms. She holds an MA in Chemistry from Oxford University.<\/span><\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=”Term of office” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}” open=”off”]<\/p>\n

Susan Searle was appointed as Non-Executive Director in March 2025.<\/span><\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=”External appointments” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}” open=”off”]<\/p>\n

Susan Searle is currently a Non-Executive Director of Gooch & Housego plc, where she is Chair of the Remuneration and Sustainability Committees, as well as being a Non-Executive of Bibby Line Group and Chair of Greenback Recycling Technologies Limited.<\/span><\/p>\n

[\/et_pb_accordion_item][\/et_pb_accordion][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.21.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/admedsol.com\/wp-content\/uploads\/2023\/08\/douglas-le-fort.png” title_text=”douglas-le-fort” align=”center” module_class=”ams-br-8 ams-bg-green-5″ _builder_version=”4.27.4″ _module_preset=”default” background_enable_color=”off” height_tablet=”” height_phone=”” height_last_edited=”on|tablet” max_height=”250px” custom_margin=”1rem||1rem||false|false” custom_padding=”0px||0px||false|false” border_radii=”on|0.5rem|0.5rem|0.5rem|0.5rem” global_colors_info=”{}”][\/et_pb_image][et_pb_code _builder_version=”4.27.4″ _module_preset=”default” custom_margin=”1rem||1rem||false|false” custom_padding=”0px||0px||false|false” global_colors_info=”{}”]<\/p>\n

<\/p>\n

Douglas Le Fort<\/h4>\n

<\/p>\n

Non-Executive Director<\/h5>\n

<\/p>\n

<\/p>\n
A<\/div>\n

<\/p>\n

R<\/div>\n

<\/p>\n

N<\/div>\n

<\/div>\n

<\/div>\n

[\/et_pb_code][et_pb_code _builder_version=”4.21.0″ _module_preset=”default” custom_margin=”1rem||1rem||false|false” custom_padding=”0px||0px||false|false” global_colors_info=”{}”]<\/p>\n

<\/div>\n

[\/et_pb_code][et_pb_accordion open_toggle_text_color=”#03305D” open_toggle_background_color=”#ffffff” closed_toggle_background_color=”#ffffff” icon_color=”#0B629F” module_class=”ams-divi-accordion” _builder_version=”4.27.4″ _module_preset=”default” toggle_text_color=”#0B629F” toggle_font=”|700|||||||” body_font=”|300|||||||” custom_margin=”0px||0px||false|false” custom_padding=”0.5rem|0px|0px|0px|false|true” border_width_all=”0px” border_color_all=”#f8f8f8″ global_colors_info=”{}”][et_pb_accordion_item title=”Biography” open=”on” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

Douglas Le Fort is a seasoned veteran in the medical and life science industry, with more than 20 years of senior executive leadership. He has expertise in business strategy, including commercial business execution, operational management and M&A. Most recently, he was a Non-Executive Director of Clinisupplies, a UK- ased manufacturer of chronic care products, CEO of MedTrade Products, a woundcare products business, and prior to that served in various senior executive roles at ConvaTec Group plc, including five years on the Executive Committee for the group. At ConvaTec he was Senior Vice President for Corporate Development, and prior to that Vice President and General Manager with P&L responsibility for the global Ostomy business. <\/span><\/p>\n

<\/span><\/p>\n

He has an MBA from Henley Management College and is a Chartered Management Accountant.<\/span><\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=”Term of office” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}” open=”off”]<\/p>\n

Douglas Le Fort was appointed as Non-Executive Director of AMS in August 2021 and as the Director responsible for Workforce Engagement in March 2025.<\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=”External appointments” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}” open=”off”]<\/p>\n

Douglas Le Fort is currently Chairman of Advanced Oxygen Therapy Inc. (AOTI), a medical technology group, an Operating Partner for Revival Healthcare Capital Partners, an investor in medical device and diagnostics businesses, as well as a Non-Executive Director at ForLife GmbH, previously Trio Healthcare and a manufacturer of ostomy products, and The Insides Company Ltd, a start-up addressing intestinal failure based in New Zealand.<\/span><\/p>\n

[\/et_pb_accordion_item][\/et_pb_accordion][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.21.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/admedsol.com\/wp-content\/uploads\/2026\/02\/Yourgene-Health.png” title_text=”Yourgene-Health” align=”center” module_class=”ams-br-8 ams-bg-teal-4″ _builder_version=”4.27.5″ _module_preset=”default” background_enable_color=”off” height_tablet=”” height_phone=”” height_last_edited=”on|tablet” max_height=”250px” custom_margin=”1rem||1rem||false|false” custom_padding=”0px||0px||false|false” border_radii=”on|0.5rem|0.5rem|0.5rem|0.5rem” locked=”off” global_colors_info=”{}”][\/et_pb_image][et_pb_code _builder_version=”4.27.4″ _module_preset=”default” custom_margin=”1rem||1rem||false|false” custom_padding=”0px||0px||false|false” locked=”off” global_colors_info=”{}”]<\/p>\n

<\/p>\n

Juliet Thompson<\/h4>\n

<\/p>\n

Non-Executive Director<\/h5>\n

<\/p>\n

<\/p>\n
A<\/div>\n

<\/p>\n

R<\/div>\n

<\/p>\n

N<\/div>\n

<\/div>\n

<\/div>\n

[\/et_pb_code][et_pb_accordion open_toggle_text_color=”#03305D” open_toggle_background_color=”#ffffff” closed_toggle_background_color=”#ffffff” icon_color=”#0B629F” module_class=”ams-divi-accordion” _builder_version=”4.27.4″ _module_preset=”default” toggle_text_color=”#0B629F” toggle_font=”|700|||||||” body_font=”|300|||||||” custom_margin=”0px||0px||false|false” custom_padding=”0.5rem|0px|0px|0px|false|true” border_width_all=”0px” border_color_all=”#f8f8f8″ locked=”off” global_colors_info=”{}”][et_pb_accordion_item title=”Biography” open=”on” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

Juliet s<\/span>pent her career advising pharmaceutical and medtech companies. She played a leading role in setting up Code Securities, which was later acquired by Nomura (becoming Nomura Code) but remained independent. At Nomura Code, Juliet advised companies in the healthcare and clean tech sectors on their financing and strategic options. She worked on over 50 transactions including IPOs, secondary offerings, private placements and M&A. As Nomura Code was devolved, she joined Stifel with a team from Nomura Code to head up the life sciences team where she advised CEOs and CFOs in the healthcare sector. She was Audit Committee Chair at Vectura Group Limited.<\/p>\n

Juliet holds a BSc in Economics from the University of Bristol and qualified as a Chartered Accountant and holds an ACA from the Association of Chartered Certified Accountants.<\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=”Term of office” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}” open=”off”]<\/p>\n

Juliet Thompson was appointed as Non-Executive Director in June 2025.<\/span><\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=”External appointments” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}” open=”off”]<\/p>\n

Juliet is currently a Non-Executive Director and Chair of the Audit Committees of: Indivior plc, a NASDAQ listed company working to develop medicines to treat addiction; Novacyt S.A., a Euronext and AIM listed diagnostic company; and Organox Limited, a private company spun out of Oxford University developing innovative solutions for organ preservation prior to transplantation.<\/p>\n

[\/et_pb_accordion_item][\/et_pb_accordion][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"

Liz Shanahan is a life sciences entrepreneur with extensive experience advising leading global pharmaceutical and healthcare organisations on their communications.<\/p>\n","protected":false},"author":4,"featured_media":797,"parent":115,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"page_collections":[],"class_list":["post-118","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"\nBoard of Directors - Advanced Medical Solutions<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/admedsol.com\/investor-relations\/corporate-governance\/board-of-directors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Board of Directors\" \/>\n<meta property=\"og:description\" content=\"Liz Shanahan is a life sciences entrepreneur with extensive experience advising leading global pharmaceutical and healthcare organisations on their communications.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/admedsol.com\/investor-relations\/corporate-governance\/board-of-directors\/\" \/>\n<meta property=\"og:site_name\" content=\"Advanced Medical Solutions\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-24T11:20:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/admedsol.com\/wp-content\/uploads\/2023\/06\/Board-of-Directors-1.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"16 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/admedsol.com\\\/investor-relations\\\/corporate-governance\\\/board-of-directors\\\/\",\"url\":\"https:\\\/\\\/admedsol.com\\\/investor-relations\\\/corporate-governance\\\/board-of-directors\\\/\",\"name\":\"Board of Directors - Advanced Medical Solutions\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/admedsol.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/admedsol.com\\\/investor-relations\\\/corporate-governance\\\/board-of-directors\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/admedsol.com\\\/investor-relations\\\/corporate-governance\\\/board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/admedsol.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Board-of-Directors-1.jpg\",\"datePublished\":\"2022-09-13T11:50:51+00:00\",\"dateModified\":\"2026-03-24T11:20:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/admedsol.com\\\/investor-relations\\\/corporate-governance\\\/board-of-directors\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/admedsol.com\\\/investor-relations\\\/corporate-governance\\\/board-of-directors\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/admedsol.com\\\/investor-relations\\\/corporate-governance\\\/board-of-directors\\\/#primaryimage\",\"url\":\"https:\\\/\\\/admedsol.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Board-of-Directors-1.jpg\",\"contentUrl\":\"https:\\\/\\\/admedsol.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Board-of-Directors-1.jpg\",\"width\":1920,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/admedsol.com\\\/investor-relations\\\/corporate-governance\\\/board-of-directors\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/admedsol.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Investor Relations\",\"item\":\"https:\\\/\\\/admedsol.com\\\/investor-relations\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Corporate Governance\",\"item\":\"https:\\\/\\\/admedsol.com\\\/investor-relations\\\/corporate-governance\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Board of Directors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/admedsol.com\\\/#website\",\"url\":\"https:\\\/\\\/admedsol.com\\\/\",\"name\":\"Advanced Medical Solutions\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/admedsol.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/admedsol.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/admedsol.com\\\/#organization\",\"name\":\"Advanced Medical Solutions\",\"url\":\"https:\\\/\\\/admedsol.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/admedsol.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/admedsol.com\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/ams-logo-on-white.webp\",\"contentUrl\":\"https:\\\/\\\/admedsol.com\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/ams-logo-on-white.webp\",\"width\":1200,\"height\":845,\"caption\":\"Advanced Medical Solutions\"},\"image\":{\"@id\":\"https:\\\/\\\/admedsol.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/advanced-medical-solutions\\\/\",\"https:\\\/\\\/uk.linkedin.com\\\/showcase\\\/advanced-medical-solutions-surgical\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/showcase\\\/advanced-medical-solutions-woundcare\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Board of Directors - Advanced Medical Solutions","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/admedsol.com\/investor-relations\/corporate-governance\/board-of-directors\/","og_locale":"en_US","og_type":"article","og_title":"Board of Directors","og_description":"Liz Shanahan is a life sciences entrepreneur with extensive experience advising leading global pharmaceutical and healthcare organisations on their communications.","og_url":"https:\/\/admedsol.com\/investor-relations\/corporate-governance\/board-of-directors\/","og_site_name":"Advanced Medical Solutions","article_modified_time":"2026-03-24T11:20:00+00:00","og_image":[{"url":"https:\/\/admedsol.com\/wp-content\/uploads\/2023\/06\/Board-of-Directors-1.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"16 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/admedsol.com\/investor-relations\/corporate-governance\/board-of-directors\/","url":"https:\/\/admedsol.com\/investor-relations\/corporate-governance\/board-of-directors\/","name":"Board of Directors - Advanced Medical Solutions","isPartOf":{"@id":"https:\/\/admedsol.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/admedsol.com\/investor-relations\/corporate-governance\/board-of-directors\/#primaryimage"},"image":{"@id":"https:\/\/admedsol.com\/investor-relations\/corporate-governance\/board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/admedsol.com\/wp-content\/uploads\/2023\/06\/Board-of-Directors-1.jpg","datePublished":"2022-09-13T11:50:51+00:00","dateModified":"2026-03-24T11:20:00+00:00","breadcrumb":{"@id":"https:\/\/admedsol.com\/investor-relations\/corporate-governance\/board-of-directors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/admedsol.com\/investor-relations\/corporate-governance\/board-of-directors\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/admedsol.com\/investor-relations\/corporate-governance\/board-of-directors\/#primaryimage","url":"https:\/\/admedsol.com\/wp-content\/uploads\/2023\/06\/Board-of-Directors-1.jpg","contentUrl":"https:\/\/admedsol.com\/wp-content\/uploads\/2023\/06\/Board-of-Directors-1.jpg","width":1920,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/admedsol.com\/investor-relations\/corporate-governance\/board-of-directors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/admedsol.com\/"},{"@type":"ListItem","position":2,"name":"Investor Relations","item":"https:\/\/admedsol.com\/investor-relations\/"},{"@type":"ListItem","position":3,"name":"Corporate Governance","item":"https:\/\/admedsol.com\/investor-relations\/corporate-governance\/"},{"@type":"ListItem","position":4,"name":"Board of Directors"}]},{"@type":"WebSite","@id":"https:\/\/admedsol.com\/#website","url":"https:\/\/admedsol.com\/","name":"Advanced Medical Solutions","description":"","publisher":{"@id":"https:\/\/admedsol.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/admedsol.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/admedsol.com\/#organization","name":"Advanced Medical Solutions","url":"https:\/\/admedsol.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/admedsol.com\/#\/schema\/logo\/image\/","url":"https:\/\/admedsol.com\/wp-content\/uploads\/2024\/01\/ams-logo-on-white.webp","contentUrl":"https:\/\/admedsol.com\/wp-content\/uploads\/2024\/01\/ams-logo-on-white.webp","width":1200,"height":845,"caption":"Advanced Medical Solutions"},"image":{"@id":"https:\/\/admedsol.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/advanced-medical-solutions\/","https:\/\/uk.linkedin.com\/showcase\/advanced-medical-solutions-surgical\/","https:\/\/www.linkedin.com\/showcase\/advanced-medical-solutions-woundcare\/"]}]}},"_links":{"self":[{"href":"https:\/\/admedsol.com\/wp-json\/wp\/v2\/pages\/118","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/admedsol.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/admedsol.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/admedsol.com\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/admedsol.com\/wp-json\/wp\/v2\/comments?post=118"}],"version-history":[{"count":0,"href":"https:\/\/admedsol.com\/wp-json\/wp\/v2\/pages\/118\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/admedsol.com\/wp-json\/wp\/v2\/pages\/115"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/admedsol.com\/wp-json\/wp\/v2\/media\/797"}],"wp:attachment":[{"href":"https:\/\/admedsol.com\/wp-json\/wp\/v2\/media?parent=118"}],"wp:term":[{"taxonomy":"page_collections","embeddable":true,"href":"https:\/\/admedsol.com\/wp-json\/wp\/v2\/page_collections?post=118"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}